FIELD: medicine, pharmacy.
SUBSTANCE: invention refers to ivabradine hydrochloride form IV with powder diffraction containing the following peaks expressed in 2 theta (±0.2) degrees: 8.74, 15.55, 17.17, 19.89 and 24.29, at that, the X-ray diffraction was measured using CuK-radiationα, as well as to pharmaceutical compositions based thereon, to methods for its preparation and application as a therapeutically active ingredient.
EFFECT: invention provides a new thermodynamically stable crystalline form of ivabradine hydrochloride with constant physical properties.
31 cl, 4 dwg, 2 tbl, 32 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE FORMS OF SAXAGLIPTIN | 2010 |
|
RU2539590C2 |
| NEW CRYSTAL SOLID COMPOUND OF 3-PHENYL-4-PROPYL-1-(PYRIDINE-2-YL)-1H-PYRAZOL-5-OL HYDROCHLORIDE | 2018 |
|
RU2754255C2 |
| S-CRYSTAL FORM OF IVABRADINE HYDROCHLORIDE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THEREOF | 2014 |
|
RU2658824C2 |
| POLYMORPHIC FORMS OF ICOTINIB AND USES THEREOF | 2014 |
|
RU2710013C2 |
| SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-cd]INDOL-6-ONE | 2011 |
|
RU2570198C2 |
| CRYSTALLINE SOLVATES OF HYDROCHLORIDE 6-(PIPERIDIN-4-YLOXY)-2H-ISOQUINOLIN-1-ONE | 2012 |
|
RU2619129C2 |
| CRYSTALLINE IRINOTECAN HYDROCHLORIDE POLYMORPHOUS FORM, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2003 |
|
RU2300535C2 |
| METHOD OF PRODUCING N-[5-(3,5-DIFTORBENZIL)-1H-INDAZOLE-3-YL]-4-(4-METHYLPIPERAZINE-1-YL)-2-(TETRAHYDROPYRAN-4-YLAMINO)BENZAMIDE | 2013 |
|
RU2602071C2 |
| POLYMORPHOUS AND AMORPHOUS FORMS OF {2-FLUORINE-5-[3-((E)-2-PYRIDINE-2-ILVINYL)-1N-INDAZOLE-6-ILAMINE]PHENYL}AMIDE 2, 5-DIMETHYL-2N-PYRAZOLE-3-CARBONIC ACID | 2005 |
|
RU2324692C1 |
| CRYSTALLINE FORM OF (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[b]THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE MONOHYDRATE | 2011 |
|
RU2577334C2 |
